Evaluation of circulating immune cells, analytes, and inflammatory markers in sows affected with postpartum dysgalactia syndrome
- PMID: 39298285
- PMCID: PMC11452653
- DOI: 10.1093/jas/skae270
Evaluation of circulating immune cells, analytes, and inflammatory markers in sows affected with postpartum dysgalactia syndrome
Abstract
Postpartum dysgalactia syndrome (PDS) is a condition affecting periparturient sows, characterized by a reduction in milk and colostrum synthesis shortly after farrowing. Insufficient milk production results in substantial economic losses due to increased piglet morbidity/mortality and premature sow culling. Since PDS develops within a few days following farrowing, the study objectives were to determine if periparturient immune cell profiles and circulating biomarkers differ in sows affected by PDS. We hypothesized differences in immune cells, circulating analytes, and inflammatory markers would exist at farrowing in sows that subsequently developed PDS compared to healthy herd-mates. Thirty-six sows with PDS symptoms were matched by parity and day of lactation with 36 healthy control (CON) sows. Diagnosis of PDS (timepoint 2) occurred on average 9.25 ± 2.67 d after farrowing. Blood samples and litter weights were collected at farrowing (timepoint 1) and at the onset of clinical PDS (timepoint 2). Piglets from PDS sows had lower average daily gain and higher mortality than piglets from CON (P < 0.01). Aspartate aminotransferase was increased (20%; P ≤ 0.06) in PDS sows compared to CON at both timepoints. Additionally, blood urea nitrogen was increased in PDS sows at timepoint 1 and timepoint 2 (13%; P = 0.08 and 16%; P = 0.01, respectively). At timepoint 2, total protein, globulin, magnesium, and cholesterol were increased (P ≤ 0.03) while γ-glutamyl transferase and albumin were decreased (P ≤ 0.02) in PDS sows. Lipopolysaccharide-binding protein, an inflammatory biomarker, was increased (48%; P = 0.07) at timepoint 2 in PDS compared to CON sows. Collectively, these data indicate PDS sows have altered metabolism and appear immune activated compared to healthy herd-mates, and further investigation is needed to determine if PDS can be predicted at farrowing.
Keywords: agalactia; dysgalactia; inflammation; metabolite; postpartum; sow.
Plain language summary
Postpartum dysgalactia syndrome (PDS) is a multifactorial disorder affecting periparturient sows characterized by a pronounced reduction (dysgalactia) in milk secretion. Insufficient milk production limits piglet growth, leading to increased piglet mortality and often removal of affected sows from the herd, ultimately compromising sow longevity and negatively impacting the profitability of swine operations. The objective of this study was to determine if differences in circulating immune cells, analytes, and inflammatory markers exist at farrowing in sows that subsequently develop PDS compared to healthy herd-mates. Thirty-six sows with PDS were matched by parity and day of lactation with 36 healthy control (CON) sows. Blood samples were collected at farrowing (timepoint 1) and at the onset of clinical PDS (timepoint 2). Differences in markers of tissue catabolism (blood urea nitrogen, β-hydroxybutyrate, aspartate aminotransferase, alanine aminotransferase) and inflammation (lipopolysaccharide-binding protein, haptoglobin, albumin) were observed in PDS sows compared to control, suggesting PDS sows have altered metabolism and are potentially immune activated compared to healthy herd-mates.
© The Author(s) 2024. Published by Oxford University Press on behalf of the American Society of Animal Science.
Conflict of interest statement
The authors report no conflict of interest. At the time the study was conducted, L.G.P. and K.A.V. were employed by Zoetis.
Figures







References
-
- Costermans, N. G. J., Soede N. M., Middelkoop A., Laurenssen B. F. A., Koopmanschap R. E., Zak L. J., Knol E. F., Keijer J., Teerds K. J., and Kemp B... 2020. Influence of the metabolic state during lactation on milk production in modern sows. Animal. 14:2543–2553. doi:10.1017/S1751731120001536 - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous